既往DAIR失败是否增加两阶段翻修术后假体周围感染再感染风险?多中心病例对照研究
该多中心病例对照研究分析了12家西班牙医院2009至2018年间因假体周围感染接受两阶段翻修的患者,比较既往DAIR失败后翻修与直接翻修者的再感染风险。调整混杂因素后,既往DAIR失败与再感染风险升高相关(调整OR 3.5,95%CI 1.4-8.8,p=0.008),慢性PJI中关联更明显但交互检验无统计学意义。
要点
- 既往DAIR失败后行两阶段翻修,再感染风险显著高于直接翻修(调整OR 3.5)。
- 慢性PJI患者中该关联更强(调整OR 4.0),但急慢性间交互检验无统计学意义。
- DAIR候选患者需严格选择,以避免影响后续两阶段翻修的成功率。
核心结论
- DAIR失败可能与两阶段翻修后再感染风险升高相关。
- 急慢性PJI间未见统计学显著差异,但慢性PJI中关联幅度可能更大。
研究设计与样本
- 基于既往回顾性病例对照研究,纳入12家西班牙医院2009至2018年因PJI行两阶段翻修的患者。
- 共89例病例和171例匹配对照,按假体部位、中心和手术年份匹配。
- 病例为再植入后2年内发生再感染,对照为2年内未发生新感染。
主要发现
- 调整年龄、性别、Charlson合并症指数和抗生素预防后,既往DAIR失败与再感染风险升高相关(调整OR 3.5,95%CI 1.4-8.8,p=0.008)。
- 慢性PJI中调整OR 4.0(95%CI 1.4-11.3,p=0.009),急性PJI中调整OR 2.2(95%CI 0.7-7.2,p=0.2),交互检验无统计学意义。
关键数值与推荐
- PJI按2018年最新标准定义;急性PJI为术后3个月内发生且为血源性,慢性PJI为3个月后发生且非血源性。
- 再感染定义为再植入后2年内基于国际共识标准发生新感染。
临床怎么用
- 对PJI患者考虑DAIR时需谨慎选择候选者,避免因DAIR失败影响后续两阶段翻修的成功。
- 慢性PJI患者若既往DAIR失败,两阶段翻修后再感染风险可能更高,应加强围手术期评估与随访。
局限性
- 证据等级为III级治疗性研究,结论需前瞻性研究确认。
- 急慢性PJI间交互检验无统计学意义,亚组关联幅度差异需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reinfection of a joint prosthesis after a two-stage revision is a serious complication, the risk of which may be higher when the procedure is performed after an unsuccessful debridement, antibiotics, and implant retention (DAIR) procedure. The available evidence is scarce and somewhat contradictory, so new studies are required. QUESTIONS/PURPOSES: (1) Is two-stage revision performed after a prior unsuccessful DAIR associated with a higher risk of prosthetic joint reinfection compared with patients who had no DAIR but rather proceeded directly to two-stage revision? (2) Does the type of periprosthetic joint infection (PJI) (acute versus chronic) modify this association? METHODS: We analyzed data from a previous retrospective, case-control study aimed at assessing the risk factors of reinfection of a joint prosthesis treated with two-stage revision in 12 Spanish hospitals between 2009 and 2018. We defined PJI according to the latest criteria published in 2018. We defined "acute PJI" as those occurring early (< 3 months after surgery) and of hematogenous origin and "chronic PJI" as those occurring after 3 months and of nonhematogenous origin. During the period in question, we found 89 cases and selected 171 matched controls. For each case (patients who developed a reinfection of a joint prosthesis within 2 years of reimplantation, based on last internationally accepted consensus criteria), up to two consecutive controls (patients who underwent two-stage revision who did not develop a new infection within 2 years of reimplantation) were included, matched by prosthesis location, center, and year of surgery. There were no differences in age, gender, comorbidities, type of infection, or microbiology between the groups. We analyzed how many patients among cases and controls received a previous DAIR, and we assessed the association of the previous DAIR with reinfection of a joint prosthesis by the OR and its respective 95% confidence interval (CI) obtained through logistic regression, adjusted for potential confounding factors. In addition, we performed a separate analysis depending on whether the PJI was acute or chronic. RESULTS: After adjusting for potentially confounding variables such as age, sex, Charlson comorbidity index, and antibiotic prophylaxis, we found that two-stage revision performed after a prior unsuccessful DAIR was associated with higher odds of prosthetic joint reinfection compared with direct two-stage revision (adjusted OR 3.5 [95% CI 1.4 to 8.8]; p = 0.008). After adjusting for confounders, we found that the odds of reinfection in two-stage revision were higher after unsuccessful DAIR compared with direct two-stage revision in patients with chronic PJI (adjusted OR 4.0 [95% CI 1.4 to 11.3]; p = 0.009) than they were in patients with acute PJI (adjusted OR 2.2 [95% CI 0.7 to 7.2]; p = 0.2), but the interaction test did not show statistical significance. CONCLUSION: Unsuccessful DAIR could be associated with a higher risk of reinfection of a joint prosthesis than in direct two-stage revision. Although no difference was found by the type of infection (acute or chronic), the association might be of greater magnitude in patients with chronic PJI, and future studies should focus on this. Although DAIR is a very attractive therapeutic option for PJI, careful selection of candidate patients is essential to avoid compromising the success of a future two-stage revision. Future prospective studies should confirm these findings and evaluate which poor prognostic factors would weigh against performing a DAIR procedure. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Barbero Allende JM, Fernández E, Gómez-Junyent J, et al. Does a Prior Unsuccessful DAIR Increase the Risk of Reinfection After a Two-stage Revision for Periprosthetic Joint Infection? Results of a Multicenter Case-control Study. Clin Orthop Relat Res. 2026. PMID: 42925226. doi:10.1097/CORR.0000000000004147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。